Is DM a real, documented Akita condition?
Yes — the SOD1 mutation associated with DM has been documented in Akitas through genetic testing.
Quick answer
Is DM a real, documented Akita condition?
Yes — the SOD1 mutation associated with DM has been documented in Akitas through genetic testing.
A senior Akita that starts dragging its rear toenails slightly, with no pain and no obvious injury, may be showing the first sign of a slow, progressive breakdown in the spinal cord's ability to relay signals to the hind legs.

Owners of senior Akitas, generally eight and older, who notice gradual hind-end weakness or coordination changes are the ones most likely to encounter this diagnosis.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
Check this first
Sudden, acute hind-end paralysis or a rapid change occurring over hours to a day or two is different from typical DM progression and warrants prompt veterinary evaluation, since a sudden onset points more toward a disc herniation or another acute spinal issue than DM's normally gradual course.
The classic gradual pattern of DM — subtle dragging of a rear paw, occasional stumbling, or slowly worsening hind-end weakness over weeks to months — is not an emergency. It warrants a scheduled veterinary neurologic exam and, ideally, genetic testing to help confirm the diagnosis and rule out other causes.
Because DM is not typically painful, a dog showing significant pain alongside hind-end weakness should be evaluated for a different or additional cause, since this doesn't fit the typical DM presentation and may indicate a separate, more urgent problem.
If any of these apply, call your vet or an emergency clinic now. The rest of this page is for the cases that are not an emergency.
Degenerative myelopathy is a progressive spinal cord disease, and Akitas are among the breeds where the associated SOD1 gene mutation has been documented through genetic testing, making this a real and confirmable senior-onset condition for the breed. It typically starts as subtle hind-end weakness and progresses gradually over one to three years without causing pain.
The SOD1 mutation associated with DM has been specifically documented in Akitas through genetic testing panels, making this a genuine, confirmable breed-relevant risk, though not every dog carrying the mutation necessarily develops clinical disease.
The Akita is among the breeds where the SOD1 gene mutation linked to DM has been genetically confirmed, which sets it apart from breeds where DM isn't well documented at all. Because this is a purely inherited condition, genetic status is the most relevant risk factor, more so than any lifestyle or environmental consideration.
DM itself isn't caused or triggered by environment since it's a genetic condition, but how consistently a diagnosed dog engages in physical therapy and moderate exercise does appear to influence how long functional mobility is maintained, based on available clinical observations.
Schedule a neurologic exam and genetic testing for gradual hind-end weakness, paw dragging, or stumbling in a senior dog. Seek prompt veterinary care for sudden, rapid hind-end paralysis occurring over hours to a day, which is inconsistent with typical DM progression and may indicate a different, more urgent cause.
Because DM's early signs can look like normal aging or a joint problem, certain habits let it advance further before being properly identified.
See all Akita health problems, which breeds are prone to degenerative myelopathy dm, or the full Akita breed guide for temperament, exercise needs and ownership costs.
DM typically progresses over one to three years from first noticeable signs to significant hind-end paralysis, though the exact pace varies by individual dog and how consistently physical therapy and exercise are maintained.
Success looks like maintaining functional mobility and quality of life for as long as possible through consistent physical therapy, appropriate mobility aids, and close monitoring, even though the underlying progression can't be stopped.
If you think your Akita has degenerative myelopathy, the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers hip dysplasia, progressive retinal atrophy, hypothyroidism.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for degenerative myelopathy it is often what separates a clear pattern from a guess.
When Dmitri noticed his nine-year-old Akita, Kenji, had started slightly dragging a rear paw during walks in Anchorage, he brought him in for evaluation. His vet recommended SOD1 genetic testing alongside a neurologic exam, which came back positive alongside clinical signs consistent with DM. Dmitri started Kenji on a structured physical therapy program with regular moderate exercise and introduced a rear-support harness early on. Two years later, Kenji still walks with some assistance but has maintained more mobility than Dmitri initially expected, which he credits directly to catching it early and staying consistent with therapy.
Key takeaway: Genetic testing combined with a neurologic exam gives real clarity on a DM diagnosis, and early, consistent physical therapy is associated with meaningfully longer functional mobility.
Yes — Akitas are among the breeds in which the SOD1 gene mutation associated with DM has been identified through genetic testing panels, making this a real, confirmable condition for the breed rather than a general assumption.
Subtle dragging of a rear paw (sometimes noticed first as unusual wear on the top of the nail), occasional stumbling or knuckling over on a back foot, and gradually worsening hind-end coordination are the classic early signs.
A genetic test (a simple cheek swab) can identify the SOD1 mutation, which supports a diagnosis when combined with a neurologic exam and ruling out other causes of hind-end weakness, such as a disc problem or orthopedic condition, often via imaging.
No — DM is generally understood to be a non-painful condition, which distinguishes it from many other causes of hind-end weakness like disc disease or advanced arthritis.
It typically progresses gradually over one to three years, moving from mild hind-end weakness to eventual paralysis, though the exact timeline varies by individual dog.
There's no cure, but physical therapy, regular moderate exercise, and mobility support (like rear-support harnesses) are associated with maintaining function longer in many documented cases compared to inactivity.
Genetic testing for the SOD1 mutation typically costs $65 to $130; ongoing physical therapy and mobility aids vary widely but commonly add several hundred dollars over the course of managing the condition.
Yes — the SOD1 mutation associated with DM has been documented in Akitas through genetic testing.
Subtle dragging of a rear paw or occasional stumbling in a senior dog, without pain.
No — it's generally considered a non-painful condition, unlike many other spinal issues.
Typically $65 to $130 for the SOD1 mutation test.
Yes — it's associated with slower progression and longer functional mobility in many cases.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





